GFAP and Alzheimer disease: When CISD2 is overexpressed in AD mice, reduced neuron loss, β-amyloid-induced mitochondrial dysfunction, and decreased immunofluorescence of Iba1 (ionized calcium-binding adapter molecule 1) and GFAP have been reported in the hippocampus [84].